Savara Announces European and Australian Patent Offices Have Granted Patents for the Liquid Formulation of MOLBREEVI*, Providing Protection in Europe and Australia Until March 2041
Go back to Savara Announces European and Australian Patent Offices Have Granted Patents for the Liquid Formulation of MOLBREEVI*, Providing Protection in Europe and Australia Until March 2041| (NASDAQ: SVRA) | Delayed: 5.45 +0.08 (1.49%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $5.37 | 52 Week High | $ | |||
| Open | $5.44 | 52 Week Low | $ | |||
| Day High | $5.51 | P/E | N/A | |||
| Day Low | $5.36 | EPS | $ | |||
| Volume | 1,311,924 | |||||
